IOVS Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2008;49:1591-1598.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1356
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, Y.
Right arrow Articles by Hartnett, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, Y.
Right arrow Articles by Hartnett, M. E.

Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model

Yuta Saito,1 Abhineet Uppal,2 Grace Byfield,2 Steven Budd,2 and M. Elizabeth Hartnett2

1From the Department of Ophthalmology, Showa University, Tokyo, Japan; and the 2Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina.


   Abstract
Top
 Abstract
Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. To study NAD(P)H oxidase-dependent outcomes after oxygen stresses that are similar to those experienced by preterm infants today using a rat model of retinopathy of prematurity.

METHODS. Within 4 hours of birth, pups and their mothers were cycled between 50% and 10% oxygen daily for 14 days and were returned to room air (21% O2, 50/10 oxygen-induced retinopathy [OIR]) or supplemental oxygen (28% O2, 50/10 OIR+SO) for 4 days. Pups received intraperitoneal injections of the specific NAD(P)H oxidase inhibitor apocynin (10 mg/kg/d) or of PBS from postnatal day (P)12 to P17, and some received intraperitoneal injections of hypoxyprobe before kill. Intravitreous neovascularization (IVNV), avascular/total retinal areas, vascular endothelial growth factor (VEGF), NAD(P)H oxidase activity, or hypoxic retina (conjugated hypoxyprobe) were determined in neurosensory retinas. Human retinal microvascular endothelial cells (RMVECs) treated with apocynin or control were exposed to 1% or 21% O2 and assayed for phosphorylated (p-)Janus kinase (JNK) and NAD(P)H oxidase activity.

RESULTS. Retinas from 50/10 OIR+SO had increased NAD(P)H oxidase activity and lower VEGF than did retinas from 50/10 OIR. Apocynin treatment reduced the IVNV area and hypoxic retina in 50/10 OIR+SO. RMVECs treated with 1% O2 had increased p-JNK compared with RMVECs exposed to room air.

CONCLUSIONS. Different oxygen stresses activate NAD(P)H oxidase to varying degrees to trigger disparate pathways (angiogenesis or apoptosis). The oxygen stresses and outcomes used in this study are relevant to human ROP and may explain some of the complexity in the pathophysiology of ROP resulting from oxygen exposure.

Oxygen level has been recognized as important in the development of retinopathy of prematurity (ROP). In the 1940s, high levels of unregulated oxygen at birth likely accounted for early cases.1 2 Several animal models of oxygen-induced retinopathy (OIR) were created,3 4 5 6 7 8 9 and, from these, it appeared a period of constant hyperoxia caused vaso-obliteration of newly formed capillaries. The ensuing relative hypoxia6 within the avascular retina that occurred when animals were returned to room air led to abnormal neovascularization into the vitreous (intravitreous neovascularization [IVNV]).

Subsequently, it was shown that supplemental oxygen reduced the severity of OIR.10 Mice raised in sustained hyperoxia beyond postnatal day (P)12 had less vaso-obliteration and neovascularization than mice exposed to the standard OIR model.11 Rats that were exposed to oxygen fluctuations and that recovered in supplemental oxygen (28%) rather than room air had reduced IVNV levels at P20 (though not at P2612 ). Despite these data showing some benefit from supplemental oxygen, the Supplemental Therapeutic Oxygen for Prethreshold ROP (STOP-ROP) multicenter clinical trial did not find an overall significant benefit from supplemental oxygen given to infants with prethreshold ROP.13 In addition, current clinical studies show that fluctuations in oxygen and increased inspired oxygen of infants are associated with higher risk for severe ROP.14 15 16 17 18 Because reducing oxygen levels is of concern for brain development in preterm infants and because supplemental oxygen is common during preterm infant examinations and procedures in neonatal intensive care units (NICUs), knowledge of specific effects of supplemental oxygen (SO) on ROP would be helpful in designing future clinical trials.

The size of the avascular zone of the retina is associated directly with poor outcomes from severe ROP.19 20 Based on studies of the avascular retina in animal models,1 2 the ischemic microenvironment created by these avascular regions was theorized to produce an angiogenic substance responsible for later neovascularization.1 21 Studies support the concept that increased apoptosis, such as through inflammatory leukostasis22 23 or seen in bcl-2 knockout mice, which have a defect in protection against apoptosis,24 leads to increased avascular zone size. Furthermore, the apoptosis of newly formed capillaries after hyperoxia-induced vaso-obliteration can be prevented by giving growth factors25 26 27 28 or nutritional supplements29 30 before the hyperoxic insult. We recently reported that the avascular peripheral retina in the rat model of ROP occurred in part from nicotinamide adenine dinucleotide (phosphate) [NAD(P)H] oxidase–dependent retinal apoptosis.31

NAD(P)H oxidase is a major enzyme responsible for the release of superoxide radicals from macrophages to fight invading microorganisms.32 It is activated by a number of stimuli relevant to ROP, including hypoxia,33 hyperoxia,34 and reactive oxygen species (ROS),33 35 36 37 and its activation can trigger disparate signaling pathways from endothelial apoptosis38 to endothelial proliferation and angiogenesis,33 outcomes relevant to human ROP. One study provides evidence that the concentration of ROS produced by NAD(P)H oxidase activation may affect what signaling pathways are triggered.39 To further study the effects of NAD(P)H oxidase under oxygen stresses, we used an animal model relevant to ROP8 that exposed newborn rat pups to repeated fluctuations in oxygen and returned the pups to room air or supplemental oxygen (28% O2). Analogous fluctuations and supplemental oxygen conditions are commonly experienced by preterm infants in NICUs today. Our goal was to determine the effect of supplemental oxygen on NAD(P)H oxidase activation and signaling pertinent to the pathogenesis in ROP, specifically the size of avascular retinal regions and the development of IVNV. Knowledge of the effects of supplemental oxygen on ROP would be helpful in designing future studies that address oxygen concentrations or fluctuations on outcomes in premature infants, not only those involving ROP but also those involving the preterm infant’s pulmonary and central nervous system status.


   Materials and Methods
Top
 Abstract
 Materials and Methods
Results
 Discussion
 References
 
All animals were cared for in accordance with the University of North Carolina’s Institute for Laboratory Animal Research (Guide for the Care and Use of Laboratory Animals) and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

50/10 Oxygen-Induced Retinopathy and Supplemental Oxygen Models
A bioactive gas controller (Oxycycler; BioSpherix, Redfield, NY), which regulates the atmosphere inside an incubator by injecting either nitrogen or oxygen, was used to induce oxygen-induced retinopathy in newborn Sprague–Dawley rats (Charles River, Wilmington, MA), as reported.8 Within 4 hours of birth, pups and their mothers were placed in the incubator, which cycled oxygen between 50% and 10% every 24 hours for 14 days. At that point, pups were returned to room air (21% O2) for 4 additional days (50/10 OIR) or to supplemental oxygen (28% O2) for 4 days (50/10 OIR+SO). Carbon dioxide in the cage was monitored and flushed from the system by maintaining sufficient gas flow and using soda lime. Litters of 12 to 14 pups were used in all experiments. Pup body weights were measured at the time of intervention, and, because body weight can affect outcomes, only those litters in which pups had mean body weights ±2 g of one another were used in experiments.40 There was no significant difference in mean body weights among groups of all litters at the time of assays at P18.

Treatment with Pimonidazole
For determination of retinal hypoxia, pups received intraperitoneal (IP) injections of the chemical analogue 2-nitroimadazole (pimonidazole; Hypoxyprobe [HP]; Chemicon, Temecula, CA) at 60 mg/kg 90 minutes before kill at P4 and P18 in room air and at P18 in 50/10 OIR or 50/10 OIR+SO. HP binds to protein thiol groups and forms adducts when oxygen levels drop below 10 mm Hg, and these can be quantified by Western blot or visualized using a fluorescence-labeled antibody. Eyes were promptly processed to reduce error in outcomes and were analyzed by immunostaining of flatmounts or cryosections or with Western blot.

Dissecting Retinal Tissue for Flatmounts and Cryosections
Pups were anesthetized by IP injection of ketamine (20 mg/kg) and xylazine (6 mg/kg). Paraformaldehyde (PFA; 1 mL, 0.5%) was directly perfused into the left ventricle before humane killing by intracardiac injection of pentobarbital (80 mg/kg). Both eyes were enucleated and fixed in 2% PFA for 2 hours. Anterior segments were removed, and retinas with intact ora serratas were carefully dissected and placed in phosphate-buffered saline (PBS), with care taken to remove the hyaloidal vessels and any remaining vitreous. For flatmounts, each retina was placed onto a microscope slide and flattened by making four incisions, each 90° apart, beginning at the ora serrata and extending centrally from the equator, stopping short of the optic nerve opening. For cryosections, retinas were put in 30% sucrose/PBS overnight. Each retina was dried with filter paper, soaked in optimal cutting temperature (OCT) compound (Tissue Tek; product no. 4583; EMS, Hatfield, PA), and kept at –80°C for future analysis. In most analyses, one eye of each pup was used for either flatmount or fresh tissue to reduce the effect of variability between pups.

Tissue Staining for Flatmounts
Flattened retinas were permeabilized in ice-cold 70% ethanol for 20 minutes and then in PBS/1% Triton X-100 for 30 minutes. The retinas were incubated with fluorescent dye (Alexa Fluor 594; Invitrogen-Molecular Probes, Carlsbad, CA)–conjugated Griffonia simplicifolia (Bandeiraea) isolectin B4 (5 µg/mL) in PBS overnight at 4°C, washed with PBS, and incubated in 5% normal goat serum to block nonspecific binding of the primary antibody for 60 minutes. For visualization of the HP-protein adducts, anti–HP mouse antibody (1:100; Chemicon) was added overnight at 4°C, then washed with PBS and incubated (1:500) with a goat anti–mouse antibody labeled with fluorescent dye (Alexa 488; Invitrogen-Molecular Probes). The retinas were rinsed in PBS, mounted in PBS-glycerol (2:1; Vectashield, Vector Laboratories, Burlingame, CA), and placed on slides with coverslips sealed with nail polish. Images of the superficial blood vessel layers were captured with an inverted microscope (TE2000U; Nikon, Tokyo Japan; Michael-Hooker Microscopy Facility, University of North Carolina, Chapel Hill) and digitally stored for analysis. Image sections were stitched with the commercial image-management software (Adobe Photoshop 7.0) and assembled using methods that maintain the original image dimensions and do not induce image distortion (Tekmate PhotoFit Premium version 1.44 or Adobe Photoshop).

Tissue Staining for Cryosections
Retinas cut into 10-µM sections (2800 Frigocut N; Reichert-Jung, Nussloch, Germany) were incubated in PBS/1% Triton X-100 for 30 minutes, then incubated with Alexa Fluor 594-conjugated G. simplicifolia (Bandeiraea) isolectin B4 (5 µg/mL; Invitrogen-Molecular Probes) in PBS for 30 minutes at room temperature. After 3 washes with PBS, retinas were incubated in 5% normal goat serum for 10 minutes to block nonspecific binding of the primary antibody. For visualization of the HP-protein adducts, anti-HP mouse antibody (1:100; Chemicon) was added for 60 minutes at room temperature, then washed with PBS, incubated (1:500) with a goat anti-mouse antibody labeled with Alexa-488 (Invitrogen-Molecular Probes) for 20 minutes. The retinas were rinsed in PBS and mounted in PBS-glycerol (2:1; Vectashield; Vector Laboratories). Images were captured with an inverted microscope (Nikon TE2000U Michael-Hooker Microscopy Facility, University of North Carolina, Chapel Hill) and digitally stored for analysis.

Fresh Tissue Preparation
Animals were humanely killed with overdoses of pentobarbital (80 mg/kg intraperitoneally). Eyes were enucleated, and retinas were isolated under a dissecting microscope in a fashion similar to that used for flatmounting except that each ora serrata was carefully removed. The tissue was placed in RIPA buffer (20 mM Tris base, 120 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 10% glycerol) with a protease inhibitor cocktail (1:100; Sigma, St. Louis, MO) and 1 M orthovanadate (1:100; Sigma) and was stored for Western blot.

Protein Extraction, Immunoprecipitation, and Western Blot Analysis
Freshly dissected unfixed retinal tissue immersed in RIPA buffer was homogenized, and lysates were centrifuged at 13000g for 15 minutes at 4°C. Supernatants were collected, and total protein in the cell lysate was determined by bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL). Fifty micrograms of protein for each sample was diluted in 2x sample buffer and was separated by 7.5% or 15% sodium dodecyl sulfate–polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride (PVDF) membrane, and reacted to anti–HP rabbit monoclonal antibody (1:1000; gift from James Raleigh, University of North Carolina, Chapel Hill) overnight, followed by goat anti–rabbit HRP–conjugated secondary antibody (1:200,000; R&D Systems, Minneapolis, MN). As a measure of NAD(P)H oxidase activation, the ratio of phospho p47phox to total was determined by immunoprecipitating 50 µg protein for each sample with p47phox antibody (1 µg; catalog no. sc-14015; Santa Cruz Biotechnology, Santa Cruz, CA) and probing with phosphoserine (1:300; catalog no. AB1603; Chemicon) to determine activated p47phox, a cytoplasmic subunit that is phosphorylated and then joins with membrane-bound subunits to produce active NAD(P)H oxidase. Total p47phox was determined after membranes were stripped (Restore Plus Western Blot Stripping Buffer; catalog no. 46430; Pierce) according to manufacturer’s protocol and were reprobed with p47phox antibody (1:500). All membranes were also probed with beta actin (1:20,000; catalog no. ab20272; Abcam, Cambridge, MA) as a control. Visualization was performed with enhanced chemiluminescence (SuperSignal Pico Luminol; Pierce). The signal intensity was quantified from exposed films with analysis software (UN-SCAN-IT, version 6.1; Silk Scientific, Orem, UT).

Treatment with Apocynin
Apocynin (4-acetovanillone) is a specific inhibitor of NAD(P)H oxidase, the enzyme mainly responsible for the release of superoxide radical in neutrophils32 and important in endothelial cell signaling.33 To test its effects with oxygen stresses, we treated half of each litter with IP injections of apocynin (Sigma-Aldrich, St. Louis, MO) in sterile PBS at 10 mg/kg (5 µL/g body weight) once a day from P12 to P17. Controls received IP injections of sterile PBS at 5 µL/g.

IVNV Area and Avascular/Total Retina Area
Digitized retinal images were randomized, labeled, and analyzed by two masked reviewers. Total retinal area and peripheral or summed avascular areas (computed in pixels and converted to square millimeters based on a calibration bar within each image) were made (ImageTool version 3; University of Texas, San Antonio, TX) and expressed as the percentage of avascular to total retinal area for each eye.41 Vascular area was the area with lectin-stained retinal vessels. IVNV has been defined as intravitreous neovascularization occurring at the junction of vascular and avascular retina.41 IVNV areas42 were measured similarly to the manner used for avascular areas, from retinal images randomized and labeled to maintain masking and using Image Tool version 3 freeware (University of Texas). Significant differences between masked reviewers were resolved by an independent third masked reviewer.

In Vitro Studies
Human retinal microvascular endothelial cells (RMVECs; Cell/Systems, Kirkland, WA) at passage 2 were grown to 70% confluence in DMEM/low glucose supplemented with 120 µg/mL endothelial cell growth supplement (Sigma) and heparin (100 µg/mL; Sigma) in 5% CO2. RMVECs were treated with either 16 µL apocynin (final concentration, 30 µg/mL) or PBS. Immediately thereafter, cells were placed in 1% O2 in a hypoxia incubator (Biospherix) or in room air (21% O2). After 6 hours, cells were removed and placed in RIPA (20 mM Tris base, 120 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 10% glycerol) with protease inhibitor cocktail (1:100; Sigma) and 1 M orthovanadate (1:100; Sigma) and were stored for ELISA and Western blot testing.

ELISA
Frozen protein samples processed from retinas or cells were thawed, or fresh samples were prepared and centrifuged (16,000g, 10 minutes, 4°C). RIPA was removed, and lysis buffer (0.15 M NaCl, 0.02 M Tris-HCl [pH 8.0], 1% NP40, 1% sodium deoxycholate, 0.1% SDS, 0.01% proteinase inhibitor cocktail; Sigma) was added. Samples were homogenized and centrifuged at 16,000g for 10 minutes at 4°C, and total protein was quantified by BCA protein assay (Pierce). Supernatants from samples prepared from rat retinas were assayed without dilution in duplicate using commercially available ELISA kits raised against rat VEGF164 isoform (R&D Systems).

It is believed that differential activation of NAD(P)H oxidase can trigger different signaling pathways.39 To test effects of oxygen stress of NAD(P)H oxidase activated signaling pathways, we used RMVECs exposed to hypoxia (1% O2) or room air and repeated with apocynin or control. Supernatants from samples were assayed without dilution in duplicate using a commercially available ELISA (DuoSet; R&D Systems) for phosphorylated Janus kinase (JNK), phosphorylated ERK, or phosphorylated Akt according to the manufacturer’s specifications.

Statistical Analysis
Data were analyzed with SPSS software (version 14.0; Chicago, IL). Individual Student’s t-tests were used to analyze parametric data, including avascular area/total retinal area (% AVA), IVNV area/total retinal area, and normalized densitometric values. For all comparisons, P < 0.05 was used as the criterion of significance.


   Results
Top
 Abstract
 Materials and Methods
 Results
Discussion
 References
 
Zones of Hypoxic and Oxygenated Retina throughout Vascularized Retina in ROP Model
We first sought to determine whether hypoxyprobe staining would delineate regions of abutting hypoxic and oxygenated retina visualized in flatmounts to determine regions possibly vulnerable to the generation of ROS. We anticipated that the junction of vascular and avascular retina would be such a region. In 50/10 OIR, we found staining for HP mainly in avascular retina and between retinal vessels in regions of vascularized retina with reduced capillary density (Fig. 1A) , showing that the junction between vascular and avascular retina was not a unique region where abutting oxygenated and poorly oxygenated retina existed. Numerous regions within the vascular retina existed that might be vulnerable to the generation of ROS. In contrast, little to no HP staining was present in the vascularized or avascular areas in flatmounts from room air–raised rats at P4, in which there were peripheral avascular retinal areas (Fig. 1B) . In cryosections of P18 50/10 OIR, HP staining was localized to the inner retinal layers (Fig. 1C) .


Figure 1
View larger version (19K):
[in this window]
[in a new window]

  		FIGURE 1. Lectin-stained (red) flatmounts and cryosections of retinas from 50/10 OIR and room air-raised pups given IP injections of pimonidazole (HP; green) 90 minutes before humane killing. (A) P18 50/10 OIR flatmount demonstrating hypoxic (green) retina in avascular zone and in regions surrounding lectin-stained blood vessels (red) in vascularized retina. (B) P4 room air-raised pup demonstrating little staining with HP, even though avascular retina is present approximately to the same extent as for P18 50/10 OIR. (C) Cryosection of eye from P18 50/10 OIR pup demonstrating inner retinal hypoxia (green) within avascular zone and some staining in ganglion cell layer in vascularized retina. Representative of eyes from three litters.

 
Inhibition of NAD(P)H Oxidase Activation under Conditions of Supplemental Oxygen
To determine the activation of NAD(P)H oxidase, we measured the phosphorylation of a cytoplasmic subunit of NAD(P)H oxidase, p47phox, ,which is phosphorylated before its assembly with cytoplasmic and membrane-bound subunits to create the active heterodimer.33 43 We found that retinas of pups in the 50/10 OIR+SO had increased phosphorylation of p47phox at P18 compared with those in 50/10 OIR (Student’s t-test, P = 0.02; Fig. 2 ), providing support that NAD(P)H oxidase was activated by supplemental oxygen after fluctuations in oxygen. Because p47phox phosphorylation occurs before the assembled active NAD(P)H oxidase heterodimer, apocynin, which inhibits assembly,33 43 44 did not inhibit p47phox phosphorylation.


Figure 2
View larger version (12K):
[in this window]
[in a new window]

  		FIGURE 2. Western blot of retinas from P18 50/10 OIR+SO and P18 50/10 OIR immunoprecipitated for NAD(P)H oxidase cytoplasmic subunit p47phox blotted for phosphoserine to determine phosphorylated p47phox/total p47phox. Total p47phox was determined after membranes were stripped and reprobed with p47phox antibody (*P ≤ 0.02; Student’s t-test). Retinas taken from at least four separate litters; at least five retinas were analyzed for each treatment group.

 
NAD(P)H Oxidase–Dependent IVNV and Tissue Hypoxia in Supplemental Oxygen
Given that 50/10 OIR+SO had greater NAD(P)H oxidase activation, we sought to determine whether its activation had an effect on IVNV or avascular retina by treating pups exposed to 50/10 OIR+SO with IP injections of the specific NAD(P)H oxidase inhibitor apocynin or of PBS from P12 to P17. Although we found no statistical difference in avascular/total retina areas (Fig. 3) or cleaved caspase 3 protein (data not shown) at P18 in apocynin versus PBS-treated pups, we found that apocynin reduced the IVNV area significantly (Student’s t-test, P = 0.047; Fig. 4 ). We also found that apocynin reduced whole retinal tissue hypoxia measured as reduced conjugated hypoxyprobe by Western blot analysis (Student’s t-test, P = 0.002; Fig. 5 ).


Figure 3
View larger version (11K):
[in this window]
[in a new window]

  		FIGURE 3. Avascular/total retina areas from pups in 50/10 OIR+SO and 50/10 OIR treated with IP injections of apocynin (10 mg/kg/d P12–P17) or an equivalent volume of PBS and assayed at P18 (P = NS). Retinas taken from at least four separate litters; at least five retinas were analyzed for each treatment group.

 

Figure 4
View larger version (12K):
[in this window]
[in a new window]

  		FIGURE 4. IVNV area from pups in 50/10 OIR+SO and 50/10 OIR treated with IP injections of apocynin (10 mg/kg/d P12–P17) or an equivalent volume of PBS and assayed at P18 (*P = 0.047; Student’s t-test). Retinas taken from at least four separate litters; at least five retinas were analyzed for each treatment group.

 

Figure 5
View larger version (11K):
[in this window]
[in a new window]

  		FIGURE 5. Ratio of hypoxyprobe/actin Western blot in 50/10 OIR+SO and 50/10 OIR treated with IP injections of apocynin (10 mg/kg/d P12–P17) or an equivalent volume of PBS and assayed at P18 (*P = 0.002; Student’s t-test). Retinas taken from two separate litters; at least five retinas were analyzed for each treatment group.

 
Effect of NAD(P)H Oxidase Inhibition on VEGF under Supplemental Oxygen
Given that NAD(P)H oxidase activation can cause angiogenesis by triggering VEGF, we measured VEGF in 50/10 OIR+SO rats treated with apocynin or PBS control and found no difference in VEGF protein at P18 (Fig. 6) . However, compared with 50/10 OIR, retinas from the 50/10 OIR+SO had reduced VEGF (Fig. 6 ; Student’s t-tests; P < 0.001 for SO+50/10 OIR and 50/10 OIR). Furthermore, 50/10 OIR+SO did not have a reduced hypoxic retina, as measured by Western blot analysis of HP (Fig. 5) . Therefore, supplemental oxygen reduced inner retinal VEGF but did not reduce hypoxic retina.


Figure 6
View larger version (11K):
[in this window]
[in a new window]

  		FIGURE 6. ELISA of VEGF from pups in 50/10 OIR or in 50/10 OIR+SO treated with either IP injections of apocynin (10 mg/kg/d) or an equivalent volume of PBS from P12–P17 and assayed at P18 (*P < 0.001; Student’s t-test). Retinas taken from at least four separate litters; at least five retinas were analyzed for each treatment group.

 
p-JNK, p-AKT, and p-ERK in Supplemental Oxygen versus Room Air
The activation of NAD(P)H oxidase can trigger disparate outcomes, such as apoptosis or endothelial proliferation. Because the concentration of ROS produced by NAD(P)H oxidase may affect what signaling pathway is activated,39 we sought to determine whether hypoxia would activate NAD(P)H oxidase and trigger certain signaling pathways in retinal endothelial cells. We tested signaling pathways relevant to outcomes in the pathogenesis of ROP and those we found in vivo. Protein kinase B (Akt) is involved in cell survival, and extracellular signal-regulated kinase (ERK) is involved in proliferation, whereas JNK is involved in pathways of apoptosis. Activation of these proteins occurs through the phosphorylation of tyrosine kinases. Therefore, we measured phosphorylated (p)-JNK, p-ERK, and p-Akt in RMVECs grown in 1% or 21% O2 for 6 hours.45 RMVECs exposed to 1% O2 had increased phosphorylation of p47phox compared with room air–exposed cells (Fig. 7) . There was undetectable p-ERK or p-Akt; however, p-JNK was increased in RMVECs in 1% O2 compared with those exposed to room air (Fig. 8) .


Figure 7
View larger version (14K):
[in this window]
[in a new window]

  		FIGURE 7. Western blot of human RMVECs treated with either apocynin (30 µg/mL final concentration) or PBS control and exposed to 1% O2 or 21% O2 for 6 hours, then immunoprecipitated for NAD(P)H oxidase cytoplasmic subunit p47phox blotted for phosphoserine to determine phosphorylated p47phox/total p47phox. Total p47phox was determined after membranes were stripped and reprobed with p47phox antibody. Individual Student’s t-tests for 1% O2 PBS versus 21% O2 PBS (*P = 0.02) and for 1% O2 PBS vs. 21% O2 apocynin (**P = 0.006). n = 4 for each treatment group.

 

Figure 8
View larger version (12K):
[in this window]
[in a new window]

  		FIGURE 8. Human RMVECs treated with either apocynin (30 µg/mL final concentration) or PBS control and exposed to 1% O2 or 21% O2 for 6 hours, then undergoing ELISA testing for phospho-JNK. Individual Student’s t-tests (*P ≤ 0.04 for 1% O2 PBS vs. 21% O2 PBS and 1% O2 PBS vs. 21% O2 apocynin). ELISA was performed in duplicate for each treatment group.

 

   Discussion
Top
 Abstract
 Materials and Methods
 Results
 Discussion
References
 
We previously found that one mechanism for the avascular retina in a rat model of ROP (Penn 50/10 OIR model) was NAD(P)H oxidase-dependent apoptosis.31 In this study, we found pups exposed to repeated oxygen fluctuations followed by supplemental oxygen (i.e., 50/10 OIR+SO)12 rather than room air (Penn 50/10 OIR) had a further increase in NAD(P)H oxidase activation, determined by increased phosphorylation of subunit p47phox46 (Fig. 2) . In addition, the inhibition of NAD(P)H oxidase activity in 50/10 OIR+SO reduced IVNV (Fig. 4) but was not associated with reduced VEGF, suggesting there are other mechanisms involving angiogenic signaling through NAD(P)H oxidase activation.

NAD(P)H oxidase is the main source of ROS, particularly superoxide radical, released by neutrophils in response to invading organisms.32 Besides neutrophils, macrophages, bone marrow-derived hematopoietic cells,47 and endothelial cells48 can activate NAD(P)H oxidase to release ROS that trigger disparate signaling events from endothelial cell survival, proliferation, and angiogenesis to endothelial apoptosis.33 It is thought that the concentration and location of ROS released by different degrees of NAD(P)H oxidase activation may trigger different signaling pathways.33 49 50 Our data and previous studies31 provide evidence of this. Here we show that supplemental oxygen (50/10 OIR+SO) further increased NAD(P)H oxidase activation over that in 50/10 OIR and is implicated in angiogenesis (Figs. 2 4) , whereas previously we found NAD(P)H oxidase activation in the 50/10 OIR was a cause of peripheral avascular retina through increased apoptosis.31 We also found that the activation of NAD(P)H oxidase and signaling of JNK was triggered in retinal microvascular endothelial cells exposed to hypoxia compared with room air (Figs. 7 8) . Previous studies reported that JNK signaling is implicated in H2O2 and stress-related apoptosis, whereas ERK activation occurred in VEGF-induced endothelial cell survival.51

We also found that the inhibition of NAD(P)H oxidase significantly reduced tissue hypoxia after supplemental oxygen (Fig. 5) but was not associated with concomitant reductions in avascular/total retina area (a source of tissue hypoxia6 ) or of VEGF (Fig. 6) . HP is given systemically 90 minutes before euthanatization and is soluble, quickly diffusing into tissues and cells, forming insoluble conjugates where oxygen tension is lower than 10 mm Hg.52 Binding to oxygen is essential, and the question as to whether redox conditions overwhelm the binding of HP to proteins in low oxygen was disproved in several studies. In the pericentral region of the liver, which has a high concentration of nitroreductase enzymes, binding of HP was assessed during anterograde and retrograde perfusion of the liver. Retrograde perfusion shifted HP binding to the then hypoxic periportal region.52 In addition, high concentrations of NADH or NADPH were shown not to overwhelm the binding of HP to hypoxic tissue.53 HP has also been correlated with other tissue features associated with hypoxia, including spatial relation to perfused vessels and inversely to proliferation54 55 and correlation with oxygen microelectrode measurements when tumor hypoxia was intentionally manipulated.56 All experimental groups in our study were treated in the same manner, and all tissue was processed within the same time frame. Although excess HP is conjugated after death and gives some background signal, the 90-minute exposure time before euthanatization causes the amount of background staining to be less than 1% of the intensity of specific binding on euthanatization. That we did not find differences in avascular/total retina may indicate that measuring the percentage of the retinal avascular area is not as sensitive as measuring conjugated proteins within hypoxic retinal cells. We therefore cannot rule out that hypoxia was related to a reduction in vascular support to the retina.

The 50/10 OIR retinal flatmounts showed hypoxic retina in the avascular zones and in zones throughout the vascular retina, suggesting that all these regions may be vulnerable to the creation of ROS. In contrast, the P4 rat pup retinal flatmount, which had peripheral avascular retina, did not have HP staining. We suspect this is because at P4, the hyaloidal circulation supplies oxygen to the retina.

Even though the inhibition of NAD(P)H oxidase activation reduced hypoxic tissue in 50/10 OIR+ SO, we were unable to find evidence that VEGF was affected (Fig. 6) . We might have missed the time point in our VEGF analysis, though previous studies showed that VEGF was elevated at P12, P14, and P18 in the 50/10 OIR model.57 58 We suspected mechanisms other than VEGF signaling, such as signaling through ROS or inflammatory cytokines,59 60 are involved in the NAD(P)H oxidase-dependent IVNV we found in 50/10 OIR+SO.

We found reduced VEGF in 50/10 OIR+ SO compared with 50/10 OIR but not reduced tissue hypoxia. Again, we took care to treat eyes equally, and our data include minimal background signal of HP after euthanatization. In the kitten OIR model, Ernest6 reported that once avascular retina occurred from hyperoxia induced vaso-obliteration, breathing oxygen did not result in an increase in preretinal oxygen over the avascular retinal areas, though it did initially cause an increase in preretinal oxygen tension over the vascular areas.6 Berkowitz et al.12 found that supplemental oxygen (SO) given over 6 days after 50/10 OIR in the rat, led to a reduced {Delta}PO2 or a difference in arterial oxygen levels after breathing 95% O2, 5% CO2 (carbogen), and 21% O2. (Carbogen breathing can relax the autoregulatory effect of retinal vessels, preventing the constriction seen in hyperoxia or hypertension.) The reduced {Delta}PO2 in the group rescued in supplemental oxygen suggested a failure in autoregulatory or perfusion reserve, and it can be interpreted as a dysfunction in constriction of retinal vessels in high oxygen or a failure of dilation in low oxygen. Because these pups also had high levels of systemic arterial PO2, lower {Delta}PO2 may indicate higher retinal vascular oxygen concentration during supplemental oxygen, which was also what Ernest found initially over the vascular retina in the kitten study.6 Cells within the inner retina (Müller cells and ganglion cells) sense hypoxia and are the major producers of VEGF.61 Increased oxygen to the retina would reduce the stimulus for VEGF expression. Meanwhile, as photoreceptor development occurs and the metabolic demand of the outer retina increases, more oxygen is required. Recent evidence implicates the photoreceptors in creating oxygen demand that results in features of severe retinopathy seen in models of ROP.62 63 Furthermore, the choroid, which is a main supplier of oxygen in the areas of avascular retina, may not be able to meet the oxygen demand because, unlike the choroid in the adult rat, the choroid in the P15 rat was unable to support increased oxygen tension with supplemental oxygen.64 Therefore, given that the metabolic demand of the photoreceptors is inadequately met by the choroidal and retinal vasculatures, it is possible that supplemental oxygen may increase oxygen tension in the retinal vasculature that has a dysfunctional autoregulatory capacity but that still leads to overall retinal hypoxia.

Thus, in the preterm infant, anatomic factors such as avascular retinal area, history of oxygen exposure, current oxygen exposure, and level of maturation of the photoreceptors may play roles in the retinal outcomes of delayed intraretinal vascularization and IVNV. Our data support that signaling events that lead to pathologic features of ROP, namely the avascular retina and IVNV, can depend on the degree of NAD(P)H oxidase activation from repeated oxygen fluctuations followed by room air or supplemental oxygen. Supplemental oxygen and fluctuations in oxygen can cause features that increase the severity of ROP. These studies help explain some of the complexity of oxygen effects in ROP. More study is required because a reduction in oxygen concentration or broad inhibition of ROS may be detrimental to the preterm infant, whose developing central nervous system requires oxygen and whose immune system and abilities to fight infection are limited.65


   Acknowledgements
 
The authors thank James Raleigh (University of North Carolina) for providing a rabbit antibody to pimonidazole (hypoxyprobe) and for his expertise and help in interpreting the data; and David Martiniuk for his help with the animal experiments and dissections and his contribution as a masked reviewer.


   Footnotes
 
Supported by National Institutes of Health/National Eye Institute Grant R01 EY015130 (MEH-PI), the American Diabetes Association Grant 1-05-RA-51 (MEH-PI), and Research to Prevent Blindness.

Submitted for publication October 19, 2007; revised November 20 and December 3, 2007; accepted February 13, 2008.

Disclosure: Y. Saito, None; A. Uppal, None; G. Byfield, None; S. Budd, None; M.E. Hartnett, None

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Corresponding author: M. Elizabeth Hartnett, Department of Ophthalmology, University of North Carolina, 6109A Neuroscience Research Building, Chapel Hill, NC 27599-7041; hartnet{at}med.unc.edu.


   References
Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38:397–430.[Free Full Text]
  2. Patz A, Eastham A, Higginbotham DH, Kleh T. Oxygen studies in retrolental fibroplasia. Am J Ophthalmol. 1953;36:1511–1522.[Web of Science][Medline][Order article via Infotrieve]
  3. Gao G, Li Y, Zhang D, et al. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 2001;489:270–276.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  4. Chan-Ling T, Gock B, Stone J. Supplemental oxygen therapy: basis for noninvasive treatment of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1995;36:1215–1230.[Abstract/Free Full Text]
  5. Smith LEH, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35:101–111.[Abstract/Free Full Text]
  6. Ernest JT, Goldstick TK. Retinal oxygen tension and oxygen reactivity in retinopathy of prematurity in kittens. Invest Ophthalmol Vis Sci. 1984;25:1129–1134.[Abstract/Free Full Text]
  7. Dorey CK, Aouididi S, Reynaud X, Dvorak HF, Brown LF. Correlation of vascular permeability factor/vascular endothelial growth factor with extraretinal neovascularization in the rat. Arch Ophthalmol. 1996;114:1210–1217.[Abstract/Free Full Text]
  8. Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularisation in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34:576–585.[Abstract/Free Full Text]
  9. McLeod DS, Crone SN, Lutty GA. Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 1996;37:1322–1333.[Abstract/Free Full Text]
  10. Phelps DL. Reduced severity of oxygen-induced retinopathy in kittens recovered in 28% oxygen. Pediatr Res. 1988;24:106–109.[Web of Science][Medline][Order article via Infotrieve]
  11. Gu X, Samuel S, El Shabrawey M, et al. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2002;43:496–502.[Abstract/Free Full Text]
  12. Berkowitz BA, Zhang W. Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP. Invest Ophthalmol Vis Sci. 2000;41:1925–1931.[Abstract/Free Full Text]
  13. The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105:295–310.[Abstract/Free Full Text]
  14. McColm JR, Cunningham S, Wade J, et al. Hypoxic oxygen fluctuations produce less severe retinopathy than hyperoxic fluctuations in a rat model of retinopathy of prematurity. Pediatr Res. 2004;55:107–113.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  15. Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995;346:1464–1465.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  16. Saito Y, Omoto T, Cho Y, et al. The progression of retinopathy of prematurity and fluctuation in blood gas tension. Graefes Arch Clin Exp Ophthalmol. 1993;231:151–156.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  17. Chow LC, Wright KW, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics. 2003;111:339–345.[Abstract/Free Full Text]
  18. Tin W, Milligan DWA, Pennefather PM, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonat Ed. 2001;84:106–110.[CrossRef]
  19. Flynn JT. Retinopathy of prematurity. Ped Clin N Am. 1987;34:1487–1516.[Web of Science][Medline][Order article via Infotrieve]
  20. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 51/2 years in premature infants with birth weights less than 1251g. Arch Ophthalmol. 2002;120:595–599.[Abstract/Free Full Text]
  21. Michaelson IC. The mode of development of the vascular system of the retina: with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK. 1948;68:137.
  22. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–1452.[Abstract/Free Full Text]
  23. Ishida S, Yamashiro K, Usui T, et al. Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease. Nat Med. 2003;9:781–789.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  24. Wang S, Sorenson CM, Sheibani N. Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2–/– mice. Dev Biol. 2005;279:205–219.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  25. Shih SC, Ju M, Liu N, Smith LEH. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest. 2003;112:50–57.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  26. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1995;1:1024–1028.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  27. Chang KH, Chan-Ling T, McFarland EL, et al. IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci USA. 2007;104:10595–10600.[Abstract/Free Full Text]
  28. Lofqvist C, Chen J, Connor KM, et al. From the cover: IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth. Proc Natl Acad Sci USA. 2007;104:10589–10594.[Abstract/Free Full Text]
  29. Neu J, Afzal A, Pan H, et al. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006;47:3151–3155.[Abstract/Free Full Text]
  30. Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of [omega]-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13:868–873.[CrossRef][Medline][Order article via Infotrieve]
  31. Saito Y, Geisen P, Uppal A, Hartnett ME. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis. 2007;13:840–853.[Web of Science][Medline][Order article via Infotrieve]
  32. Fialkow L, Wang Y, Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med. 2007;42:153–164.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  33. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc Res. 2006;71:226–235.[Abstract/Free Full Text]
  34. Parinandi NL, Kleinberg MA, Usatyuk PV, et al. Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2003;284:L26–L38.[Abstract/Free Full Text]
  35. Penn JS. Oxygen-induced retinopathy in the rat: vitamins C and E as potential therapies. Invest Ophthalmol Vis Sci. 1992;33:1836–1845.[Abstract/Free Full Text]
  36. Niesman MR, Johnson KA, Penn JS. Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity. Neurochem Res. 1997;22:597–605.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  37. Penn JS, Tolman BL, Bullard LE. Effect of a water-soluble vitamin E analog, Trolox C, on retinal vascular development in an animal model of retinopathy of prematurity. Free Radic Biol Med. 1997;22:977–984.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  38. Jay Forman H, Torres M. Redox signaling in macrophages. Mol Aspects Med. 2001;22:189–216.[CrossRef][Medline][Order article via Infotrieve]
  39. Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. AJP Regul Integrative Comp Physiol. 2004;287:R1014–R1030.[CrossRef]
  40. Holmes JM, Duffner LA. The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr Eye Res. 1996;15:403–409.[Web of Science][Medline][Order article via Infotrieve]
  41. Hartnett ME, Martiniuk DJ, Saito Y, et al. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2006;47:4975–4982.[Abstract/Free Full Text]
  42. Penn JS, McCollum GW, Barnett JM, et al. Angiostatic effect of penetrating ocular injury: role of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci. 2006;47:405–414.[Abstract/Free Full Text]
  43. Hart BA, Simons JM. Metabolic activation of phenols by stimulated neutrophils: a concept for a selective type of anti-inflammatory drug. BioTechnol Therapeutics. 1992;3:119–135.
  44. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol. 1994;11:95–102.[Abstract]
  45. Al Shabrawey M, Bartoli M, El Remessy AB, et al. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am J Pathol. 2005;167:599–607.[Abstract/Free Full Text]
  46. Selemidis S, Dusting GJ, Peshavariya H, Kemp-Harper BK, Drummond GR. Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells. Cardiovasc Res. 2007;75:349–358.[Abstract/Free Full Text]
  47. Piccoli C, D'Aprile A, Ripoli M, et al. Bone-marrow derived hematopoietic stem/progenitor cells express multiple isoforms of NADPH oxidase and produce constitutively reactive oxygen species. Biochem Biophys Res Comm. 2007;353:965–972.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  48. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem. 2005;V264:85–97.[CrossRef][Web of Science]
  49. Barbieri SS, Eligini S, Brambilla M, Tremoli E, Colli S. Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte to macrophage differentiation: critical role of NADPH oxidase. Cardiovasc Res. 2003;60:187–197.[Abstract/Free Full Text]
  50. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245–313.[Abstract/Free Full Text]
  51. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res. 2000;87:179–183.[Abstract/Free Full Text]
  52. Arteel GE, Thurman RG, Yates JM, Raleigh JA. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer. 1995;72:889–895.[Web of Science][Medline][Order article via Infotrieve]
  53. Arteel GE, Thurman RG, Raleigh JA. Reductive metabolism of the hypoxia marker pimonidazole is regulated by oxygen tension independent of the pyridine nucleotide redox state. Eur J Biochem. 1998;253:743–750.[Web of Science][Medline][Order article via Infotrieve]
  54. Rijken PFJW, Bernsen HJJA, Peters JPW, et al. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Physics. 2000;48:571–582.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  55. Kennedy AS, Raleigh JA, Perez GM, et al. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int J Radiat Oncol Biol Physics. 1997;37:897–905.[CrossRef][Web of Science][Medline][Order article via Infotrieve]
  56. Raleigh JA, Chou SC, Arteel GE, Horsman MR. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res. 1999;151:580–589.[Web of Science][Medline][Order article via Infotrieve]
  57. Werdich XQ, Penn JS. Specific involvement of Src family kinase activation in the pathogenesis of retinal neovascularization. Invest Ophthalmol Vis Sci. 2006;47:5047–5056.[Abstract/Free Full Text]
  58. Geisen P, Peterson L, Martiniuk D, et al. Neutralizing antibody to VEGF reduces intravitreous neovascularization and does not interfere with vascularization of avascular retina in an ROP model. Mol Vis. 2008;14:345–357.[Medline][Order article via Infotrieve]
  59. Armstrong D, Ueda T, Ueda T, et al. Expression of TNF-alpha and VEGF during retinal neovascularization is initiated by lipid hydroperoxide. Angiogenesis. 1997;1:174–184.[CrossRef]
  60. Armstrong D, Ueda T, Aljeda A, et al. Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of TNF-alpha, VEGF, and PDGF. Angiogenesis. 1998;2:93–104.[CrossRef][Medline][Order article via Infotrieve]
  61. Robinson GS, Pierce EA, Rook SL, et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA. 1996;93:4851–4856.[Abstract/Free Full Text]
  62. Akula JD, Hansen RM, Martinez-Perez ME, Fulton AB. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4351–4359.[Abstract/Free Full Text]
  63. Berkowitz BA, Roberts R, Penn JS, Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4733–4740.[Abstract/Free Full Text]
  64. Cringle SJ, Yu PK, Su EN, Yu DY. Oxygen distribution and consumption in the developing rat retina. Invest Ophthalmol Vis Sci. 2006;47:4072–4076.[Abstract/Free Full Text]
  65. Jankov RP, Negus A, Tanswell AK. Antioxidants as therapy in the newborn: some words of caution. Pediatr Res. 2001;50:681–687.[Web of Science][Medline][Order article via Infotrieve]



This article has been cited by other articles:


Home page
 IOVSHome page
G. Byfield, S. Budd, and M. E. Hartnett
The Role of Supplemental Oxygen and JAK/STAT Signaling in Intravitreous Neovascularization in a ROP Rat Model
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3360 - 3365.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saito, Y.
Right arrow Articles by Hartnett, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saito, Y.
Right arrow Articles by Hartnett, M. E.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS